Article
Lateral Temporal Lobe: An Early Imaging Marker of the Presymptomatic GRN Disease?
Journal of Alzheimer's disease : JAD - 1 Jan 2015
Caroppo Paola, Habert Marie-Odile, Durrleman Stanley, Funkiewiez Aurélie, Perlbarg Vincent, Hahn Valérie, Bertin Hugo, Gaubert Malo, Routier Alexandre, Hannequin Didier, Deramecourt Vincent, Pasquier Florence, Rivaud-Pechoux Sophie, Vercelletto Martine, Edouart Geoffrey, Valabregue Romain, Lejeune Pascal, Didic Mira, Corvol Jean-Christophe, Benali Habib, Lehericy Stephane, Dubois Bruno, Colliot Olivier, Brice Alexis, Le Ber Isabelle
Abstract excerpt
The preclinical stage of frontotemporal lobar degeneration (FTLD) is not well characterized. We conducted a brain metabolism (FDG-PET) and structural (cortical thickness) study to detect early changes in asymptomatic GRN mutation carriers (aGRN+) that were evaluated longitudinally over a 20-month period. At baseline, a left lateral temporal lobe hypometabolism was present in aGRN+ without any structural changes....
Topics
- Adult
- Asymptomatic Diseases
- Disease Progression
- Female
- Fluorodeoxyglucose F18
- Frontal Lobe
- Frontotemporal Lobar Degeneration
- Humans
